Christopher Samler (Partner)

An entrepreneur and investor with extensive CEO experience in venture funded and turnaround situations in European healthcare and business service companies. In 1997, he was appointed Weston Medical Group's first CEO and led it from concept through several rounds of funding to a full UK listing in 2000. Prior to this he was the first CEO of Imutran, a Cambridge-based healthcare company that was sold to the Swiss based pharmaceutical multinational, Novartis. He co-founded Iceni Capital in 2005 and became Chairman of TQ Education and Training which was sold to Pearson plc in 2011. He was asked to stay on and is now President, Venture Markets for the Pearson Group. He holds an MA from the University of Oxford and an MBA from the Harvard Business School.